首页 | 本学科首页   官方微博 | 高级检索  
     


Harnessing human dendritic cell subsets for medicine
Authors:Hideki Ueno  Nathalie Schmitt  Eynav Klechevsky  Alexander Pedroza-Gonzalez  Toshimichi Matsui  Gerard Zurawski  SangKon Oh  Joseph Fay  Virginia Pascual  Jacques Banchereau  Karolina Palucka
Affiliation:1. Baylor Institute for Immunology Research and INSERM U899, Dallas, TX, USA.;2. Baylor Institute for Immunology Research and INSERM U899, Dallas, TX, USA.

Sammons Cancer Center, Baylor University Medical Center, Dallas, TX, USA.;3. Baylor Institute for Immunology Research and INSERM U899, Dallas, TX, USA.

Department of Gene and Cell Medicine and Department of Medicine (Clinical Immunology Division), Immunology Institute, Mount Sinai School of Medicine, New York, NY, USA.

Abstract:Summary: Immunity results from a complex interplay between the antigen-non-specific innate immune system and the antigen-specific adaptive immune system. The cells and molecules of the innate system employ non-clonal recognition receptors including lectins, Toll-like receptors, NOD-like receptors, and helicases. B and T lymphocytes of the adaptive immune system employ clonal receptors recognizing antigens or their derived peptides in a highly specific manner. An essential link between innate and adaptive immunity is provided by dendritic cells (DCs). DCs can induce such contrasting states as immunity and tolerance. The recent years have brought a wealth of information on the biology of DCs revealing the complexity of this cell system. Indeed, DC plasticity and subsets are prominent determinants of the type and quality of elicited immune responses. In this article, we summarize our recent studies aimed at a better understanding of the DC system to unravel the pathophysiology of human diseases and design novel human vaccines.
Keywords:dendritic cells  human  vaccines
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号